MX9300883A - VACCINE POLYPEPTIDES. - Google Patents

VACCINE POLYPEPTIDES.

Info

Publication number
MX9300883A
MX9300883A MX9300883A MX9300883A MX9300883A MX 9300883 A MX9300883 A MX 9300883A MX 9300883 A MX9300883 A MX 9300883A MX 9300883 A MX9300883 A MX 9300883A MX 9300883 A MX9300883 A MX 9300883A
Authority
MX
Mexico
Prior art keywords
vaccine polypeptides
vaccine
polypeptides
influenza
provides
Prior art date
Application number
MX9300883A
Other languages
Spanish (es)
Inventor
Allan Shatzman
Miller Scott
Susan B Dillon
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MX9300883A publication Critical patent/MX9300883A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención provee una inyección de vacuna capaz de conferir inmunidad de cepas múltiples contra influenza A e influenza B.The present invention provides a vaccine injection capable of conferring multiple strain immunity against influenza A and influenza B.

MX9300883A 1992-02-18 1993-02-18 VACCINE POLYPEPTIDES. MX9300883A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83777392A 1992-02-18 1992-02-18

Publications (1)

Publication Number Publication Date
MX9300883A true MX9300883A (en) 1994-08-31

Family

ID=25275375

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9300883A MX9300883A (en) 1992-02-18 1993-02-18 VACCINE POLYPEPTIDES.

Country Status (3)

Country Link
AU (1) AU3724093A (en)
MX (1) MX9300883A (en)
WO (1) WO1993015763A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766601A (en) * 1990-08-08 1998-06-16 University Of Massachusetts Medical Center Cross-reactive influenza a immunization
WO1994022917A1 (en) * 1993-04-05 1994-10-13 University Of Massachusetts Medical Center Cross-reactive influenza a immunization
DE69536091D1 (en) * 1994-01-27 2010-09-09 Univ Massachusetts Medical Immunization by vaccination of DNA transcription unit
GB0004269D0 (en) * 2000-02-23 2000-04-12 Smithkline Beecham Biolog Novel compounds
US7811574B2 (en) 2000-02-23 2010-10-12 Glaxosmithkline Biologicals S.A. Tumour-specific animal proteins
PT1265915E (en) * 2000-02-23 2011-02-07 Glaxosmithkline Biolog Sa Novel compounds
GB0022969D0 (en) * 2000-09-19 2000-11-01 Chiron Spa Influenza a virus subtype H16
WO2007061969A2 (en) * 2005-11-18 2007-05-31 Rutgers, The State University Vaccines against influenza a and influenza b
RU2009105099A (en) 2006-07-14 2010-08-27 Санофи Пастер Байолоджикс Ко. (Us) CONSTRUCTION OF RECOMBINANT VIRAL VACCINES BY DIRECT TRANSPOSION-MEDIATED INSERATION OF ALIEN IMMUNOLOGICAL DETERMINANTS IN VECTOR VIRUS PROTEINS
MX2009003300A (en) 2006-09-29 2009-08-12 Sanofi Pasteur Biologics Co Recombinant rhinovirus vectors.
MX2011012623A (en) 2009-05-27 2011-12-14 Glaxosmithkline Biolog Sa Casb7439 constructs.
WO2016083287A1 (en) 2014-11-24 2016-06-02 Intervet International B.V. Inactivated equine influenza virus vaccines
CN110003314B (en) * 2019-04-11 2023-06-09 上海市计划生育科学研究所 Epitope peptide capable of inducing broad-spectrum protective antibody by H1N1 influenza virus hemagglutinin and application thereof

Also Published As

Publication number Publication date
AU3724093A (en) 1993-09-03
WO1993015763A1 (en) 1993-08-19

Similar Documents

Publication Publication Date Title
MX9300883A (en) VACCINE POLYPEPTIDES.
NO964966D0 (en) Lactobacillus strains of human origin, mixtures and their use
BR9607458A (en) Hepatitis B vaccine
ES2195181T3 (en) SUBJECT HOLDERS.
EP0831873A4 (en) The treatment of hiv and other viral infections using combinatory therapy
EP0597008A4 (en) Improved expression of influenza a m2 protein in baculovirus and uses of m2 protein.
DE59406139D1 (en) MEDICAL PLIERS
NO982497D0 (en) Vaccine compositions for ingestion through the nose
ITRM920047A0 (en) SYRINGE NEEDLE PROTECTION DEVICE OR SIMILAR.
TW240232B (en)
MX9300550A (en) ABSORBENT FIBER STRUCTURE.
ES2162110T3 (en) DERIVATIVES OF ANTIMALARY QUINOLINE.
ES2089923T3 (en) COMPOSITION OF A LIVING RECOMBINANT SUBUNITARY VACCINE AND PREPARATION PROCEDURE.
IT9048070A0 (en) PROCEDURE FOR CALIBRATING AN ELECTRIC REMOTE CONTROL DEVICE OF THE MANIPULATOR OR SIMILAR TYPE, AND A DEVICE STRUCTURED TO CARRY OUT SUCH PROCEDURE.
BR9604853A (en) Chlamydia vaccines
ES2061295T3 (en) CONICAL DUST PROTECTION COVER FOR CONICAL SPEAKER.
DE69112755D1 (en) Control device with reduced slip of the final deflection.
ATE161709T1 (en) HAIR TREATMENT PRODUCTS
CY2008005I1 (en) MUMPS VACCINE CONTAINING THE JERYL-LYNN STRAIN VIRUS
MX9405371A (en) NAFTILE DERIVATIVE.
FR2692473B1 (en) Disposable contra-angle head and contra-angle thus equipped.
AT399451B (en) DENTAL HANDPIECE
ES2042481T1 (en) SYNTHETIC PEPTIDES DERIVED FROM THE HBC ANTIGEN FROM HEPATITIS B VIRUS.
ITRM930665A0 (en) SAFETY CRUTCH DEVICE FOR WARDROBE OF PUBLIC AND PRIVATE ENVIRONMENTS.
KR920016349U (en) Electric massage chair with pressure sensor